Resources

Category: Blog Posts

Global pharma leaders reviewing their options

Keys to SCA implementation success

Technology can be a game-changer that streamlines complex processes, enhances productivity and increases efficiency. For Life Sciences organizations, a structured component authoring (SCA) platform can help transform the medical authoring and documentation process — as long as you can get everyone on board. With this in mind, we’re sharing our top three tips for a successful SCA implementation.

Global pharma leaders review an outdated document-based system, searching for authoritative, traceable information needed to answer regulatory questions and manage lifecycle change with confidence.

Why SCA has been a great idea that never achieved its promise, until now.

On the surface, structured component authoring (SCA) is a concept that makes sense in theory but has been hard to implement for many organizations. Much of the medical authoring and documentation done today is accomplished through standard desktop publishing programs like Microsoft Word — but these programs are not designed with Life Sciences authors in mind.

Hand holding cloud-based data represents governed structured content that preserves authority, metadata, and traceability as regulated information moves securely across systems and lifecycle change.

Power what’s possible with structured component authoring

Imagine this: you’re working on groundbreaking innovations for the Life Sciences industry. Your team is composed of multiple people with various specialties, spread across time zones (and sometimes, continents). There are clinical trials, endless regulatory and ethics requirements, and countless changes to critical documentation  in the authoring process. You might be on the cusp of changing the world — yet you’re using Microsoft Word to manage and publish your information.

See what structured component authoring can do for you.

Scroll to Top